Belladonna And Opium Suppository
Product Images NDC 0574-7040

7 FDA label images from Padagis Us Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Belladonna And Opium (NDC 0574-7040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Table 1 (Image 01)

Table 1 (Image 01)
Chemical structure diagram showing the molecular structure of Atropa Belladonna's active ingredient. The diagram includes carbon, hydrogen, nitrogen, and oxygen atoms arranged in a bicyclic ring system with an ester functional group attached to a benzene ring.*
FDA Label Image

Table 2 (Image 02)

Table 2 (Image 02)
Chemical structure diagram depicting the molecular structure of an active ingredient in Belladonna and Opium suppository. The diagram shows atoms and bonds, including carbon, hydrogen, oxygen, and a nitrogen-methyl group arranged in a ring and side chains.*
FDA Label Image

Table 3 (Image 03)

Table 3 (Image 03)
Chemical structure of the active ingredient in Belladonna and Opium suppository. The diagram shows a complex molecular structure featuring hydroxyl groups, a methyl group, and nitrogen atoms along with interconnected rings typical of alkaloid compounds such as atropine or related tropane alkaloids.*
FDA Label Image

16.2 mg/30 mg Carton (Carton 4d8)

16.2 mg/30 mg Carton (Carton 4d8)
Packaging label for Belladonna and Opium Suppositories 16.2 mg/30 mg by Padagis US LLC. The label indicates each suppository contains powdered Opium 30 mg and powdered Belladonna Extract 16.2 mg. The box contains 12 suppositories for rectal use only, with easy-open plastic packets and tapered shape for insertion. The label includes the NDC 0574-7045-12 and a barcode.*
FDA Label Image

Serialization (Image 04)

Serialization (Image 04)
A product label panel for Belladonna and Opium suppository showing placeholder text fields for serial number (S/N), lot number, and expiration date (Exp). The label includes instructions to insert the specific product serial number, lot number, and expiration date.*
FDA Label Image

16.2 mg/60 mg Carton (Carton 7y6)

16.2 mg/60 mg Carton (Carton 7y6)
Belladonna and Opium Suppositories 16.2 mg/60 mg rectal suppositories packaging label. The carton contains 12 suppositories and is labeled for prescription use only by Padagis US LLC. The label notes each suppository contains powdered Opium 60 mg and powdered Belladonna Extract 16.2 mg, with warnings about habit forming. Packaging highlights easy-open plastic packets and tapered shape for insertion.*
FDA Label Image

Serialization (Image 05)

Serialization (Image 05)
A label panel space for serial number (S/N), lot number, and expiration date fields, with placeholders indicating where to insert the product's serial number, lot number, and expiration date. This panel appears intended for regulatory or tracking information on the Belladonna and Opium suppository product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.